🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    THC

    phase 1 small molecule completed

    1 trial

  2. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule active

    1 trial

  3. Placebo

    BioXcel Therapeutics

    Alcohol Use Disorder (AUD)

    phase 1 small molecule completed

    1 trial

  4. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial

  5. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Memory

    phase 1 small molecule completed

    1 trial

  6. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    phase 1 small molecule completed

    1 trial

  7. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    D-limonene and THC Pharmacodynamics

    phase 1 small molecule completed

    1 trial

  8. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial

  9. Placebo Aprepitant

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Withdrawal

    phase 1 small molecule completed

    1 trial

  10. Placebo and Oxycodone

    BRIGHT MINDS BIOSCIENCES INC.

    Hypercapnia

    phase 1 small molecule completed

    1 trial

  11. Placebo for antibiotic

    Seres Therapeutics

    Metastatic Melanoma

    phase 1 small molecule completed

    1 trial

  12. Placebo oral capsule

    Biogen

    Healthy

    phase 1 small molecule completed

    1 trial

  13. Placebo pills for 14-day intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Controls

    phase 1 small molecule active

    1 trial

  14. Pomaglumetad methionil

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule terminated

    1 trial

  15. Pramipexole

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    phase 1 small molecule completed

    1 trial

  16. Pretomanid

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  17. Probiotic

    The First People's Hospital of Lianyungang

    Microbiota

    phase 1 small molecule active

    1 trial

  18. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule completed

    1 trial

  19. QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]

    Quantum Biopharma

    Essential Hypertension

    phase 1 small molecule completed

    2 trials

  20. QRL-101 Dose A

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  21. Quemliclustat

    Arcus Biosciences

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  22. Quercetin (dietary supplement)

    BRIGHT MINDS BIOSCIENCES INC.

    Fanconi Anemia

    phase 1 small molecule completed

    1 trial

  23. R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7

    PDS Biotechnology Corp

    High-risk HPV Infection and Biopsy-proven CIN1

    phase 1 mab completed

    1 trial

  24. RAD 001 in combination with Caelyx

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources